O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/17/2020ACC: 0001209191-20-050874
Officer· Chief Medical Officer
Since Jun 2018
+144.00
Net shares
Net buyer
$940.32
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
144.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+72.00
Price / share
$13.06
Trade value
$940.32
% of position
3.2%
9/15/2020
2.23K→2.30K
Total
Net shares
+72.00
Net value
$940.32
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2020 | A · Award | +72.00 | $13.06 | $940.32 | 3.2% | 2.23K | 2.30K |
| Total | +72.00 | $940.32 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
72.00 shares
Shares
+72.00
Strike price
15.37
Held after
72.00
Exercisable
—
9/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock72.00 shares | 9/15/2020 | A · Award | +72.00 | 15.37 | — | 72.00 |